ChemoSen Cancer Research Results
ChemoSen, chemo-sensitization: Click to Expand ⟱
| Source: |
| Type: |
The effectiveness of chemotherapy by increasing cancer cell sensitivity to the drugs used to treat them, which is known as “chemo-sensitization”.
Chemo-Sensitizers:
-Curcumin
-Resveratrol
-EGCG
-Quercetin
-Genistein
-Berberine
-Piperine: alkaloid from black pepper
-Ginsenosides: active components of ginseng
-Silymarin
-Allicin
-Lycopene
-Ellagic acid
-caffeic acid phenethyl ester
-flavopiridol
-oleandrin
-ursolic acid
-butein
-betulinic acid
|
Diabetic, Diabetic: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
*neuroP↑, *Inflam↓, *antiOx↑, *cardioP↑, *NRF2↑, *AMPK↑, *SOD↑, *Catalase↑, *GSH↑, *GPx↑, *ROS↓, *TNF-α↓, *IL6↓, *NF-kB↓, *COX2↓, *glucose↓, *TRPC1↓, *Ca+2↓, *HO-1↑, *NF-kB↓, *PPARα↝, *Hif1a↓, *JNK↓, *BP↓, *AntiDiabetic↑, *hepatoP↑, *TLR4↓, *NRF2↑, *Casp↓, *neuroP↑, *Aβ↓, *LDH↓, *MDA↓, *memory↑, *AChE↓, *eff↑, EMT↝, N-cadherin↓, E-cadherin↑, TumCCA↑, ROS↑, p‑P53↑, HO-1↑, NRF2↑, ChemoSen↑, mtDam↑, Casp3↑, Casp9↑, PARP↑, Bax:Bcl2↑, TumCG↓, cycD1/CCND1↓, cMyc↓, CDK2↓, mitResp↓, Glycolysis↓, Hif1a↓, PCNA↓, p‑GSK‐3β↓, VEGF↓, PI3K↓, Akt↓, mTOR↓, OS↑,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
*AntiDiabetic↑, *AMPK↑, *glyC↓, *ROS↓, *cardioP↑, *neuroP↑, *Half-Life↝, *toxicity↝, *BioAv↑, *glucose↓, *AGEs↓, AntiCan↑, Risk↓, TumCP↓, Apoptosis↑, TumCCA↑, cycD1/CCND1↓, pRB↓, p27↓, mTOR↓, Casp↑, ROS↑, MMP↓, ChemoSen↑, *hepatoP↑, *CRM↑, *Insulin↓,
| - |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
*antiOx↑, *Inflam↓, *eff↝, *selenoP↑, *Bacteria↓, *neuroP↑, *ROS↓, ChemoSen↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Diabetic, |
NA |
|
|
|
- |
Review, |
Obesity, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
- |
Review, |
Arthritis, |
NA |
|
|
|
*antiOx↑, *ROS↓, *Inflam↓, *Bacteria↓, AntiTum↑, IronCh↑, *HDL↑, *LDL↓, *BioAv↝, *Half-Life↝, *BioAv↑, *SOD↑, *GPx↑, *GSTs↑, *eff↑, radioP↑, *MDA↓, *other↑, *COX1↓, *COX2↓, *AntiAg↑, *RNS↓, *NO↓, *H2O2↓, *NOS2↓, *NADH↓, *Imm↑, Apoptosis↑, TumCP↓, angioG↓, TumCMig↓, Ca+2↑, TumCCA↑, DNAdam↑, BAX↑, Casp9↑, Casp8↑, Casp3↑, cl‑PARP↑, AIF↑, i-ROS↑, MMP↓, Cyt‑c↑, APAF1↑, Ca+2↑, MMP9↓, MMP2↓, PKCδ↓, ERK↓, H2O2↑, BAX↑, Bcl-2↓, DNAdam↑, lipid-P↑, ChemoSen↑, chemoP↑, *cardioP↑, *SOD↑, *Catalase↑, *GPx↑, *GSH↑, *BP↓, *AntiDiabetic↑, *Obesity↓, RenoP↑, *GastroP↑, hepatoP↑, *AChE↓, *cognitive↑, *BChE↓, *other↓, *BioAv↑,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
H2O2↑, 1, HO-1↑, 1, lipid-P↑, 1, NRF2↑, 1, ROS↑, 2, i-ROS↑, 1,
Metal & Cofactor Biology ⓘ
IronCh↑, 1,
Mitochondria & Bioenergetics ⓘ
AIF↑, 1, mitResp↓, 1, MMP↓, 2, mtDam↑, 1,
Core Metabolism/Glycolysis ⓘ
cMyc↓, 1, Glycolysis↓, 1,
Cell Death ⓘ
Akt↓, 1, APAF1↑, 1, Apoptosis↑, 2, BAX↑, 2, Bax:Bcl2↑, 1, Bcl-2↓, 1, Casp↑, 1, Casp3↑, 2, Casp8↑, 1, Casp9↑, 2, Cyt‑c↑, 1, p27↓, 1,
Transcription & Epigenetics ⓘ
pRB↓, 1,
DNA Damage & Repair ⓘ
DNAdam↑, 2, p‑P53↑, 1, PARP↑, 1, cl‑PARP↑, 1, PCNA↓, 1,
Cell Cycle & Senescence ⓘ
CDK2↓, 1, cycD1/CCND1↓, 2, TumCCA↑, 3,
Proliferation, Differentiation & Cell State ⓘ
EMT↝, 1, ERK↓, 1, p‑GSK‐3β↓, 1, mTOR↓, 2, PI3K↓, 1, TumCG↓, 1,
Migration ⓘ
Ca+2↑, 2, E-cadherin↑, 1, MMP2↓, 1, MMP9↓, 1, N-cadherin↓, 1, PKCδ↓, 1, TumCMig↓, 1, TumCP↓, 2,
Angiogenesis & Vasculature ⓘ
angioG↓, 1, Hif1a↓, 1, VEGF↓, 1,
Drug Metabolism & Resistance ⓘ
ChemoSen↑, 4,
Functional Outcomes ⓘ
AntiCan↑, 1, AntiTum↑, 1, chemoP↑, 1, hepatoP↑, 1, OS↑, 1, radioP↑, 1, RenoP↑, 1, Risk↓, 1,
Total Targets: 60
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
antiOx↑, 3, Catalase↑, 2, GPx↑, 3, GSH↑, 2, GSTs↑, 1, H2O2↓, 1, HDL↑, 1, HO-1↑, 1, MDA↓, 2, NADH↓, 1, NRF2↑, 2, RNS↓, 1, ROS↓, 4, selenoP↑, 1, SOD↑, 3,
Mitochondria & Bioenergetics ⓘ
Insulin↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 2, CRM↑, 1, glucose↓, 2, glyC↓, 1, LDH↓, 1, LDL↓, 1, PPARα↝, 1,
Cell Death ⓘ
Casp↓, 1, JNK↓, 1,
Transcription & Epigenetics ⓘ
other↓, 1, other↑, 1,
Migration ⓘ
AntiAg↑, 1, Ca+2↓, 1, TRPC1↓, 1,
Angiogenesis & Vasculature ⓘ
Hif1a↓, 1, NO↓, 1,
Barriers & Transport ⓘ
GastroP↑, 1,
Immune & Inflammatory Signaling ⓘ
COX1↓, 1, COX2↓, 2, IL6↓, 1, Imm↑, 1, Inflam↓, 3, NF-kB↓, 2, TLR4↓, 1, TNF-α↓, 1,
Synaptic & Neurotransmission ⓘ
AChE↓, 2, BChE↓, 1,
Protein Aggregation ⓘ
AGEs↓, 1, Aβ↓, 1,
Drug Metabolism & Resistance ⓘ
BioAv↑, 3, BioAv↝, 1, eff↑, 2, eff↝, 1, Half-Life↝, 2,
Clinical Biomarkers ⓘ
BP↓, 2, IL6↓, 1, LDH↓, 1, NOS2↓, 1,
Functional Outcomes ⓘ
AntiDiabetic↑, 3, cardioP↑, 3, cognitive↑, 1, hepatoP↑, 2, memory↑, 1, neuroP↑, 4, Obesity↓, 1, toxicity↝, 1,
Infection & Microbiome ⓘ
Bacteria↓, 2,
Total Targets: 63
Scientific Paper Hit Count for: ChemoSen, chemo-sensitization
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:61 Cells:% prod#:% Target#:1106 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page